Shayne Y. Huff, Ph.D.

/My focus

I represent clients at every stage in the development and procurement of intellectual property rights to secure worldwide protection that aligns with their business objectives in the biotechnology and life sciences field. I bring over 15 years of experience in the life sciences space and a wide breadth of scientific knowledge in the areas of molecular and cell biology as tools for diagnostics and therapeutics, including gene therapy, regenerative medicine, immunology-based diagnostics/therapeutics, and neurological disease therapy.

I work with each individual client to identify and secure patent protection for their technology through patent landscape analysis coupled with strategic counseling and patent procurement leading to the development of a worldwide patent portfolio. I also provide ongoing management of complex patent portfolios coupled with patent landscape monitoring on both a domestic and global scale. This is all done with particular focus on cost-effectiveness, prioritization, and expense allocation.

Services include:

• Development, management, and coordination of US portfolios
• Development, management, and coordination of foreign portfolios including Europe, Canada, Australia, China, Japan, Brazil, Korea, and Russia
• Analysis of patentability and freedom-to-operate
• Development, oversight, and coordination of in-licensed patent portfolios

Representative scientific fields include:

• Molecular biology, cell biology and biochemistry: the production of recombinant nucleic acid and their protein products, transgenic animals, cell lines, stem cells, virology and vaccine development
• Immunology: immunodiagnostics, hypoimmune technology, antibody development, and vaccine development
• Therapeutics: gene therapy, cell therapy, cancer therapeutics, HIV therapeutics, autoimmune disease therapeutics, immunobased therapeutics and diagnostics; disease biomarkers; microvesicle-based therapeutics
• Regenerative Medicine: tissue engineering and generation, prosthetics, stem cell therapeutics
• Diagnostics: personalized medicine (diagnostic and prognostic) microvesicle based diagnostics, immunobased diagnostic assays, and stem cells based diagnostics
• Devices: medical devices, on-site diagnostic devices, nucleic acid extraction devices and hydrogels

/Representative experience

• Currently working closely with a University based startup company to develop and manage a portfolio based on the development and use of biological sensors for pathogen detection and elimination.
• Currently working with a university and licensee to secure patent rights for breast cancer diagnostics tracking miRNA expression.
• Successfully defended a European patent for a companion diagnostic in cancer therapy in an Opposition (P 106 731 EPPC).

/Looking ahead

Advances in the fields of cellular and gene therapeutics continue to translate into clinical advances in disease therapeutics.